Coronary stent thrombosis: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 10: | Line 10: | ||
===[[Introduction]]=== | ===[[Introduction]]=== | ||
===[[Definitions | ===[[Definitions of coronary stent thombosis (ST)|Definitions]]=== | ||
==Incidence | ==Incidence== | ||
[[Incidence of coronary stent thrombosis (ST) in bare metal stents (BMS)|Relation to Bare Metal Stents]] | [[Incidence of coronary stent thrombosis (ST) in drug eluting stents (DES)|Relation to Drug Eluting Stents]] | [[Incidence of drug eluting stent thrombosis (ST) in relation to antiplatelet medication use|Relation to antiplatelet medications]] | [[Incidence of coronary stent thrombosis (ST) in bare metal stents (BMS)|Relation to Bare Metal Stents]] | [[Incidence of coronary stent thrombosis (ST) in drug eluting stents (DES)|Relation to Drug Eluting Stents]] | [[Incidence of drug eluting stent thrombosis (ST) in relation to antiplatelet medication use|Relation to antiplatelet medications]] | ||
===[[Mechanism and | ===[[Stent thrombosis mechanism and pathophysiology|Mechanism and Pathophysiology]]=== | ||
===[[Predictors of coronary stent thrombosis]]=== | ===[[Predictors of coronary stent thrombosis|Predictors]]=== | ||
===[[Treatment of coronary stent thrombosis]]=== | ===[[Treatment of coronary stent thrombosis|Treatment]]=== | ||
===[[Prognosis of coronary stent thrombosis]]=== | ===[[Prognosis of coronary stent thrombosis|Prognosis]]=== | ||
===[[Prevention of ST|Prevention | ===[[Prevention of ST|Prevention]]=== | ||
===[[Future Directions]]=== | ===[[Future Directions]]=== | ||
Revision as of 13:51, 17 May 2011
| Cardiology Network |
 Discuss Coronary stent thrombosis further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editors-In-Chief: Allen Jeremias, M.D., SUNY; Don Cutlip, M.D. Beth Israel Deaconess Medical Center, Harvard
Associate Editors-In-Chief: Priyantha Ranaweera, M.D.; William J. Gibson, MIT
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Introduction
Definitions
Incidence
Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Relation to antiplatelet medications
Mechanism and Pathophysiology
Predictors
Treatment
Prognosis
Prevention
Future Directions
Sources
- Singh M Et al. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current eta (the mayo clinc experince). Am J Cardiol 2001;88:1091-6
- White CJ et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinicla tool. Circulation 1996;93:253-8
- G Sianos, et al. Angiographic stent thrombosis after routine use of drug eluting stents in ST -Segement elevation myocardial infarction, the importance of thrombus burden. JACC, Vol 50, No 7, 2007
- C. Spaulding, et al. Sirolimus-Eluting versus Uncoated Stents in acute myocardial infarction, N Engl J Med 2006;355:1093-104.
- Menichelli M . Sirolimus stent versus bare stent in acute myocardial infarction trail, Presented at European Percutaneou Cororanry Revascularizaton 2006.
External links
- The MD TV: Comments on Hot Topics, State of the Art Presentations in Cardiovascular Medicine, Expert Reviews on Cardiovascular Research
- Clinical Trial Results: An up to dated resource of Cardiovascular Research